US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

93.11

-0.5300-0.57%

Post-market: 93.110.00000.00%16:10 EDT

Volume:5K

Turnover:509.94K

Market Cap:404.10M

PE:51.92

High:93.54

Open:92.72

Low:92.62

Close:93.64

52wk High:98.82

52wk Low:67.69

Shares:4.34M

Float Shares:4.34M

Volume Ratio:0.46

T/O Rate:0.13%

Dividend:1.55

Dividend Rate:1.66%

EPS(TTM):1.79

EPS(LYR):18.65

ROE:24.76%

ROA:0.08%

PB:1.63

PE(LYR):4.99

Loading ...

Overview Company News Filings

Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors

Alnylam, Ionis Fall as Heart-Drug Data Raise Doubts over Combination Treatment

Political and General News Events from August 28

Biogen CEO Viehbacher to Speak at Morgan Stanley Global Healthcare Conference

Amgen’s AMG 691 Phase 1 Trial Targets Key Growth in Asian Markets

Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Amgen (AMGN)

HBM Holdings FY26 H1 Profit Falls 11.16% to US$ 64.85 Million; Revenue Rises 20.9% to US$ 122.49 Million

Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements

Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints

AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients

MT Newswires Live

Vertex Corp. Added to JPX-Nikkei Mid and Small Cap Index for FY2026

Vertex Corp. Refines Leadership Structure at Key Subsidiary Vertex Co.

AstraZeneca-Amgen Asthma Drug Succeeds in Late-Stage Oesophagus Disease Trial

Amgen - Tezspire Safety Profile Consistent with Approved Indications

THOMSON REUTERS

Tezspire® Demonstrates Positive Phase 3 Results in Eosinophilic Esophagitis Across Both Co-Primary and All Key Secondary Endpoints

THOMSON REUTERS

Vertex to Present at Wells Fargo Healthcare Investor Conference Fireside Chat

Biogen CFO Robin Kramer to Join Wells Fargo Healthcare Conference Fireside Chat

Sino Biopharmaceutical Stock Climbs 2.1% in Hong Kong, Outperforms Competitors

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Political and General News Events from August 25

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/PBE/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":93.11,"timestamp":1789502400000,"preClose":93.64,"halted":0,"volume":5484,"hourTrading":{"tag":"盘后","latestPrice":93.11,"preClose":93.11,"latestTime":"16:10 EDT","volume":8,"amount":744.88,"timestamp":1789503007471,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.005659974369927393,"floatShares":4340000,"shares":4340000,"eps":1.793292,"marketStatus":"Post-Mkt","change":-0.53,"latestTime":"09-15 18:10:14 EDT","open":92.72,"high":93.535,"low":92.62,"amount":509939,"amplitude":0.009771,"askPrice":99.98,"askSize":30,"bidPrice":84.2,"bidSize":100,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":93.64,"sharesOutstanding":3180000,"nav":92.8444,"aum":404801584,"dividendRate":0.016594,"bidAskSpread":0.002045,"postHourTrading":{"tag":"盘后","latestPrice":93.11,"preClose":93.11,"latestTime":"16:10 EDT","volume":8,"amount":744.88,"timestamp":1789503007471,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.461274,"impliedVol":0.1827,"impliedVolPercentile":0.4183},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4340000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":0.461274,"shares":4340000,"dividePrice":1.5451,"high":93.535,"amplitude":0.009771,"preClose":93.64,"low":92.62,"week52Low":67.69,"pbRate":"1.63","psRate":"235.40","week52High":98.82,"institutionHeld":0.2552,"latestPrice":93.11,"committee":0.538462,"eps":1.793292,"divideRate":0.016594,"volume":5484,"delay":0,"ttmEps":1.793292,"open":92.72,"prevYearClose":82.15,"prevWeekClose":92.91,"prevMonthClose":96.68,"prevQuarterClose":89.6486,"fiveDayClose":94.89,"twentyDayClose":94.7167,"sixtyDayClose":84.6404},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PBE","amount":0.13047,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.02834,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663225097","title":"Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663225097","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663225097?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:30","pubTimestamp":1787934627,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s latest psoriasis study update spotlights apremilast (AMG 407) for ki...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-pediatric-psoriasis-study-wrap-up-what-apremilast-safety-data-means-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-pediatric-psoriasis-study-wrap-up-what-apremilast-safety-data-means-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2089984988.USD","LU2112291526.USD","BK4534","LU1057294990.SGD","LU0109394709.USD","BIB","AMGN","BK4211","LU0122379950.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BBH","PBE","BK4581","BK4585","LU0289739699.SGD","LU2242646821.SGD","LU1061106388.HKD","IE0002141913.USD","LU2468319806.SGD","IE00BJT1NW94.SGD","ISBC","LU0320765992.SGD","BK4599","IE00BFTCPJ56.SGD","LU2242652126.USD","BK4139","IE0009355771.USD","LU1571399168.USD","BK4533","TBXU","LU0889565916.HKD","BK4588","SG9999001440.SGD","LU0868494617.USD","LU0058720904.USD","IBB","IBBQ","LU1983299246.USD","IE00BJJMRZ35.SGD","LU1023059063.AUD","PJP","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662933990","title":"Alnylam, Ionis Fall as Heart-Drug Data Raise Doubts over Combination Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662933990","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662933990?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:43","pubTimestamp":1787921001,"startTime":"0","endTime":"0","summary":"BUZZ-Alnylam, Ionis fall as heart-drug data raise doubts over combination treatment** Shares of Alnylam PharmaceuticalsALNY.Ofall 5.3% to $224, while those of Ionis PharmaceuticalsIONS.Ofall 1.3% to $","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4N44P0XT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNMX","LU0109394709.USD","LU0320765992.SGD","BK4139","ALNY","LU0114720955.EUR","LU0882574055.USD","BK4585","BK4588","BK4548","PBE","LU0889565916.HKD","IONS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662098405","title":"Political and General News Events from August 28","url":"https://stock-news.laohu8.com/highlight/detail?id=2662098405","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662098405?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:30","pubTimestamp":1787920229,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 28Aug 28 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4N44P0YN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4139","IE00B4R5TH58.HKD","BK4599","LU1057294990.SGD","LU0058720904.USD","LU1023059063.AUD","LU0889565916.HKD","TBXU","AMGN","IE00B2B36J28.USD","LU2468319806.SGD","BK4585","PJP","SG9999001440.SGD","LU1983299246.USD","LU1571399168.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU0868494617.USD","LU0320765992.SGD","PBE","BK4588","BIB","LU1061106388.HKD","IBBQ","BBH","LU0122379950.USD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4566","LU2242652126.USD","IBB","IE00BJJMRZ35.SGD","BK4533","BK4581","LU2242646821.SGD","LU2112291526.USD","LU2089984988.USD","LU0289739699.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662389720","title":"Biogen CEO Viehbacher to Speak at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662389720","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662389720?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:10","pubTimestamp":1787861436,"startTime":"0","endTime":"0","summary":"Biogen CEO Viehbacher to speak at Morgan Stanley Global Healthcare ConferenceBiogen CEO Christopher A. Viehbacher to join a fireside chat at Morgan Stanley’s 24th Annual Global Healthcare Conference on Sept. 14, 2026.Webcast scheduled for 9:15 a.m. ET.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biogen Inc. published the original content used to generate this news brief on August 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL8TV47S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234570918.USD","BK4533","BK4585","IE00B894F039.SGD","LU0109394709.USD","PBE","IE00B19Z9P08.USD","LU0889565916.HKD","LU0320765992.SGD","BK4139","BK4588","BIIB","BMED","IE00B19Z9Z06.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662084187","title":"Amgen’s AMG 691 Phase 1 Trial Targets Key Growth in Asian Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2662084187","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662084187?lang=en_us&edition=fundamental","pubTime":"2026-08-28 00:31","pubTimestamp":1787848308,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) has started a new Phase 1 trial called “A Phase 1, Open-La...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-amg-691-phase-1-trial-targets-key-growth-in-asian-markets?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-amg-691-phase-1-trial-targets-key-growth-in-asian-markets?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B4R5TH58.HKD","LU1571399168.USD","LU0058720904.USD","LU0109394709.USD","IE00BFTCPJ56.SGD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU0320765992.SGD","BK4581","LU0122379950.USD","IE00BJT1NW94.SGD","AMGN","IBBQ","LU0289739699.SGD","BK4139","IE00B2B36J28.USD","SG9999001440.SGD","BBH","PJP","IBB","TBXU","IE0009355771.USD","LU1061106388.HKD","BK4533","LU2242646821.SGD","LU2112291526.USD","IE0002141913.USD","PBE","LU1983299246.USD","BK4588","BK4534","LU0868494617.USD","BK4566","LU1057294990.SGD","BBC","BIB","BK4599","LU1023059063.AUD","BK4585","LU2089984988.USD","LU2468319806.SGD","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662813780","title":"Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662813780","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662813780?lang=en_us&edition=fundamental","pubTime":"2026-08-27 23:20","pubTimestamp":1787844046,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Verrica Pharmaceuticals (VRCA) and Amgen (AMGN). Verrica Pharmace...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-verrica-pharmaceuticals-vrca-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-verrica-pharmaceuticals-vrca-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIB","SG9999001440.SGD","IE0002141913.USD","BK4139","BK4585","LU2468319806.SGD","IBB","LU0128526141.USD","LU2089984988.USD","IE00BJT1NW94.SGD","TBXU","BK4581","LU0868494617.USD","IE00BFTCPJ56.SGD","PJP","XLV","BK4566","HCSG","BK4588","IE00B4R5TH58.HKD","BK4599","BBH","LU1057294990.SGD","LU2242652126.USD","LU0889565916.HKD","IBBQ","LU0109394709.USD","BK4534","IE00B2B36J28.USD","LABU","PBE","LU0320765992.SGD","LU1571399168.USD","BK4533","LU1023059063.AUD","LU2112291526.USD","BK4137","LU0289739699.SGD","VRCA","LU2242646821.SGD","XBI","LU0029874061.USD","LU1983299246.USD","LU0058720904.USD","LU0122379950.USD","LU1061106388.HKD","BK4007","IE00BJJMRZ35.SGD","AMGN","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662084083","title":"HBM Holdings FY26 H1 Profit Falls 11.16% to US$ 64.85 Million; Revenue Rises 20.9% to US$ 122.49 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662084083","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662084083?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:01","pubTimestamp":1787839287,"startTime":"0","endTime":"0","summary":"HBM Holdings FY26 H1 profit falls 11.16% to US$ 64.85 million; revenue rises 20.9% to US$ 122.49 millionHBM Holdings posted revenue of US$122.49 million for the six months ended June 30, 2026, up 20.9","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL77D5HK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","LU1983299246.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","SG9999001440.SGD","BK4534","IE0002141913.USD","LU2089984988.USD","LU0889565916.HKD","LU2242652126.USD","LU0289739699.SGD","LU0320765992.SGD","LU1023059063.AUD","LU0058720904.USD","TBXU","BK4585","PJP","LU2242646821.SGD","BBH","PBE","BK4139","BK1574","IBBQ","LU2112291526.USD","BK4566","BIB","IE0009355771.USD","BK1583","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU1057294990.SGD","BK1161","LU0109394709.USD","LU0868494617.USD","AMGN","IBB","LU0122379950.USD","BK4588","LU1571399168.USD","BK4581","BK4533","02142","IE00BFTCPJ56.SGD","LU2468319806.SGD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662013447","title":"Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements","url":"https://stock-news.laohu8.com/highlight/detail?id=2662013447","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662013447?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:15","pubTimestamp":1787829352,"startTime":"0","endTime":"0","summary":"Positive high-level results from the Phase III CROSSING trial in patients with eosinophilic esophagitis showed that AstraZeneca (AZN) and Amgen’s (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-announce-crossing-trial-showed-meaningful-improvements-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-announce-crossing-trial-showed-meaningful-improvements-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","PBE","LU0029864427.USD","BK4566","IE00BJJMRZ35.SGD","LU2089984988.USD","LU0122379950.USD","BBH","TBXU","AZN","LU2237443382.USD","LU1057294990.SGD","BK4588","BK4007","LU2236285917.USD","AMGN","LU2468319806.SGD","BK4568","IBB","LU2242646821.SGD","LU2242652126.USD","LU1829250122.USD","LU2417539215.USD","IE00B2B36J28.USD","BK4139","PJP","IE0002141913.USD","AZNH","LU2237443978.SGD","BK4581","BK4533","LU2237443622.USD","BK4585","LU2456880835.USD","IBBQ","LU0128525929.USD","LU2462157665.USD","LU0868494617.USD","BIB","LU1267930573.SGD","LU0432979614.USD","BK4534","LU2237443465.HKD","LU1023059063.AUD","LU0708994859.HKD","IE00B4R5TH58.HKD","IE0009355771.USD","IE00BJT1NW94.SGD","LU0289739699.SGD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662877754","title":"Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2662877754","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662877754?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:15","pubTimestamp":1787822113,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 CROSSING trial of Tezspire in patients living with eosinophilic esop...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-report-crossing-trial-met-co-primary-and-secondary-endpoints-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-report-crossing-trial-met-co-primary-and-secondary-endpoints-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2456880835.USD","TBXU","LU0868494617.USD","LU1023059063.AUD","LU1057294990.SGD","LU2112291526.USD","IBBQ","LU0122379950.USD","LU0432979614.USD","LU2236285917.USD","LU1571399168.USD","LU0889565916.HKD","LU1829250122.USD","AMGN","PJP","BK4533","BK4599","IE0009355771.USD","LU0128525929.USD","LU0289739699.SGD","BK4566","IBB","IE00BJT1NW94.SGD","BK4568","BIB","IE00B2B36J28.USD","AZN","IE00BFTCPJ56.SGD","LU2237443895.HKD","AZNH","IE00B3T34201.USD","LU0320765992.SGD","LU2237443465.HKD","BK4585","LU2417539215.USD","LU0058720904.USD","LU2468319806.SGD","PBE","LU0029864427.USD","LU1061106388.HKD","LU1267930573.SGD","BK4588","IE00BJJMRZ35.SGD","BK4007","IE0002141913.USD","LU1983299246.USD","BBH","LU2242646821.SGD","LU2237443978.SGD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662771175","title":"AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2662771175","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662771175?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:24","pubTimestamp":1787819085,"startTime":"0","endTime":"0","summary":"AstraZeneca  and Amgen  said Thursday their drug Tezspire met the primary endpoints of a Phase 3 trial treating eosinophilic esophagitis, a chronic inflammatory esophagus disorder.The medication met both primary endpoints by reducing tissue inflammation and easing swallowing difficulties at week 24 compared to a placebo, the companies said.The disease and symptom improvements were maintained through week 52 for both tested doses, they said.The companies also said the safety profile of the treatment during the study remained consistent with its previously approved uses.Shares of Amgen were down by over 1% in Thursday premarket activity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BJJMRZ35.SGD","AMGN","BK4566","LU0109394709.USD","LU1057294990.SGD","LU2237443978.SGD","LU2112291526.USD","LU2237443895.HKD","BK4581","IE00BJT1NW94.SGD","BIB","AZNH","PJP","LU0889565916.HKD","LU2237443549.SGD","LU0128525929.USD","IE00BFTCPJ56.SGD","LU2242652126.USD","LU0310800379.SGD","BBH","IE00B4R5TH58.HKD","LU1571399168.USD","BK4533","LU0058720904.USD","LU0868494617.USD","LU2456880835.USD","LU0708994859.HKD","IBBQ","LU2242646821.SGD","LU0289739699.SGD","LU0432979614.USD","LU1829250122.USD","IBB","LU1983299246.USD","BK4007","IE00B2B36J28.USD","PBE","LU2237443622.USD","LU2237443465.HKD","LU1061106388.HKD","LU0029864427.USD","BK4534","BK4585","LU2237443382.USD","LU1267930573.SGD","LU2462157665.USD","LU2089984988.USD","TBXU","AZN","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662775710","title":"Vertex Corp. Added to JPX-Nikkei Mid and Small Cap Index for FY2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662775710","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662775710?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:55","pubTimestamp":1787813720,"startTime":"0","endTime":"0","summary":"The latest update is out from Vertex Corp. ( ($JP:5290) ). Vertex Corporation has been selected as a constituent of the JPX-Nikkei Mid and Small Ca...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-corp-added-to-jpx-nikkei-mid-and-small-cap-index-for-fy2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-corp-added-to-jpx-nikkei-mid-and-small-cap-index-for-fy2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBE","LU2462157665.USD","BK4532","IE00BFTCPJ56.SGD","JPX","SG9999001176.USD","BK4567","BK4023","LU1559883803.SGD","LU0234570918.USD","LU1815336091.USD","BBH","VRTX","IBBQ","LU0289739699.SGD","VERX","LU0823416689.USD","TBXU","LU0079474960.USD","IE0002141913.USD","LU1585245621.USD","LU0566484027.USD","IE0002270589.USD","LU2456880835.USD","SG9999013999.USD","IE00B4R5TH58.HKD","IE00B19Z9P08.USD","BIB","IBB","LU0109394709.USD","IE00B19Z3581.USD","LU1093756168.USD","LU1778281490.HKD","SGXZ57979304.SGD","LU1430594728.SGD","LU1069344957.HKD","BK4585","LU2089984988.USD","LU2468319806.SGD","BK4533","IE00B2B36J28.USD","IDNA","IE00B19Z9Z06.USD","GNMX","IE00BJJMRZ35.SGD","LU0058720904.USD","IE00BJT1NW94.SGD","LU0432979614.USD","IE00BZ9MQY76.HKD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662477574","title":"Vertex Corp. Refines Leadership Structure at Key Subsidiary Vertex Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2662477574","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662477574?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:55","pubTimestamp":1787813711,"startTime":"0","endTime":"0","summary":"The latest update is out from Vertex Corp. ( ($JP:5290) ). Vertex Corporation has updated its earlier disclosures on changes to directors and offic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-corp-refines-leadership-structure-at-key-subsidiary-vertex-co?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-corp-refines-leadership-structure-at-key-subsidiary-vertex-co?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z3581.USD","IE00B19Z9Z06.USD","LU0079474960.USD","LU0757428866.USD","LU1430594728.SGD","LU2236285917.USD","LU0256863811.USD","BIB","LU2417539215.USD","LU1559883803.SGD","LU0289739699.SGD","LU0823416689.USD","IE0002270589.USD","LU1674673428.USD","LU2456880835.USD","PBE","LU2362541513.USD","LU0320765992.SGD","BBH","TBXU","GNMX","LU0061475181.USD","LU0234570918.USD","LU0417517546.SGD","LU1093756325.SGD","IDNA","IBB","BK4567","LU2362541273.HKD","BK4139","LU1035775433.USD","VRTX","BK4533","LU0889565916.HKD","LU2462157665.USD","IE00BZ9MQY76.HKD","LU0566484027.USD","LU1815336091.USD","SGXZ57979304.SGD","BK4585","SG9999001176.USD","VERX","LU0109394709.USD","IE00B19Z9P08.USD","BK4532","BK4023","IE00B2B36J28.USD","IE00BJT1NW94.SGD","IBBQ","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662514775","title":"AstraZeneca-Amgen Asthma Drug Succeeds in Late-Stage Oesophagus Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662514775","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662514775?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:40","pubTimestamp":1787812818,"startTime":"0","endTime":"0","summary":"UPDATE 3-AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trialAug 27 (Reuters)-AstraZenecaAZN.Lsaid on Thursday its asthma drug Tezspire met the main goals of a late-stage tria","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL6N44O0DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU3187612489.SGD","LU0266013472.USD","LU0887340254.USD","AMGN","LU1571399168.USD","LU2237443382.USD","LU1481600234.SGD","IBBQ","LU1829250122.USD","REGN","LU2242652126.USD","PBE","LU0047473722.EUR","LU0432979614.USD","IBB","LU1974910355.USD","03165","LU0738911758.USD","LU1119994496.HKD","PJP","BBH","LU0997586515.USD","LU0972486137.USD","LU0310799852.SGD","LU0575583348.USD","LU0122379950.USD","LU0052756011.USD","TBXU","LU1153584641.USD","LU0077335932.USD","LU0997586432.USD","LU1267930490.SGD","BK4588","LU1057294990.SGD","LU2293690082.USD","LU1003077747.HKD","LU0823434583.USD","LU1170363599.USD","SGXZ57979304.SGD","BK4599","LU0661504455.SGD","LU0640478417.SGD","AZN.UK","BIB","LU0792757196.USD","LU0345777659.USD","LU1880407132.USD","LU2237443622.USD","LU1051770623.HKD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662778025","title":"Amgen - Tezspire Safety Profile Consistent with Approved Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2662778025","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662778025?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA3XV48Z:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","BK4599","LU1983299246.USD","PBE","IE00BFTCPJ56.SGD","LU0868494617.USD","BK4581","IE0002141913.USD","TBXU","BIB","AMGN","LU1061106388.HKD","LU0289739699.SGD","IE00B4R5TH58.HKD","LU1057294990.SGD","LU2468319806.SGD","IBBQ","BK4588","LU0320765992.SGD","PJP","BBH","IE00BJJMRZ35.SGD","LU1571399168.USD","SG9999001440.SGD","LU2242646821.SGD","BK4139","IE00B2B36J28.USD","LU2089984988.USD","LU2242652126.USD","BK4534","LU0058720904.USD","BK4585","BK4566","IBB","IE00BJT1NW94.SGD","LU0889565916.HKD","BK4533","LU0122379950.USD","LU2112291526.USD","LU0109394709.USD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662728778","title":"Tezspire® Demonstrates Positive Phase 3 Results in Eosinophilic Esophagitis Across Both Co-Primary and All Key Secondary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2662728778","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662728778?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA3XV48Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1571399168.USD","IE00BFTCPJ56.SGD","PJP","LU2242646821.SGD","BK4566","BK4585","BBH","LU2242652126.USD","LU0320765992.SGD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU2089984988.USD","PBE","IBB","LU1057294990.SGD","BK4588","IBBQ","BK4581","LU0868494617.USD","LU1983299246.USD","BK4534","TBXU","IE0009355771.USD","IE00BJT1NW94.SGD","LU1023059063.AUD","LU1061106388.HKD","LU0109394709.USD","AMGN","SG9999001440.SGD","IE0002141913.USD","LU0122379950.USD","IE00B4R5TH58.HKD","BIB","LU0058720904.USD","LU2112291526.USD","BK4533","BK4139","LU0289739699.SGD","IE00B2B36J28.USD","BK4599","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662741464","title":"Vertex to Present at Wells Fargo Healthcare Investor Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2662741464","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662741464?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:00","pubTimestamp":1787774425,"startTime":"0","endTime":"0","summary":"Vertex to present at Wells Fargo healthcare investor conference fireside chatVertex will join four investor conference fireside chats in September 2026, led by senior management.Wells Fargo 21st Annua","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL7VGD1d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","LU1674673691.USD","SG9999001176.USD","LU1035775433.USD","IE00B19Z3B42.SGD","GNMX","LU2362540622.SGD","BK4533","IE0002141913.USD","BK4567","LU0109394709.USD","IE00BFTCPJ56.SGD","LU2468319806.SGD","LU1069344957.HKD","PBE","IBBQ","IE00B2B36J28.USD","TBXU","LU0058720904.USD","IE00B19Z9P08.USD","BK4139","IE00B894F039.SGD","LU0289739699.SGD","LU0417517546.SGD","IBB","IE00B19Z3581.USD","LU2362541513.USD","LU1430594728.SGD","IE00B4R5TH58.HKD","SG9999013999.USD","BIB","IE0009355771.USD","LU0256863811.USD","LU2462157665.USD","LU0234570918.USD","LU0079474960.USD","LU2362541273.HKD","LU0320765992.SGD","LU2089984988.USD","SGXZ57979304.SGD","IE00BJT1NW94.SGD","LU0432979614.USD","LU2417539215.USD","VRTX","IDNA","IE00B19Z9Z06.USD","LU1778281490.HKD","LU1093756168.USD","LU0889565916.HKD","LU1674673428.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662184267","title":"Biogen CFO Robin Kramer to Join Wells Fargo Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2662184267","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662184267?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:59","pubTimestamp":1787741942,"startTime":"0","endTime":"0","summary":"Biogen CFO Robin Kramer to join Wells Fargo Healthcare Conference fireside chatBiogen will join a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Sept. 9, 2026 at 9:30 a.m. ET.Pa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL9qnkfK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","LU0109394709.USD","IE00B894F039.SGD","LU0889565916.HKD","PBE","BK4588","IE00B19Z9P08.USD","IE00B19Z9Z06.USD","LU0234570918.USD","BK4139","LU0320765992.SGD","BK4533","BK4532","BIIB","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662796495","title":"Sino Biopharmaceutical Stock Climbs 2.1% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662796495","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662796495?lang=en_us&edition=fundamental","pubTime":"2026-08-26 16:32","pubTimestamp":1787733120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 2.1% to 5.74 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.6% to 25652.97.This was the stock's second consecutive day of gains.Sino Biopharmaceutical Ltd. closed 37% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 1.2% and Amgen Inc. remained unchanged.Trading volume totaled 180.5 million shares, compared to the 50-day average of 101.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","BBH","IE00B2B36J28.USD","AMGN","LU1061106388.HKD","LU0889565916.HKD","BK4566","IE00BZ08YT58.USD","BK1191","LU0058720904.USD","HK0000165453.HKD","IE0009355771.USD","BK4588","IBB","IE00BZ08YR35.GBP","LU0109394709.USD","LU0868494617.USD","BIB","LU1571399168.USD","LU1057294990.SGD","LU1023059063.AUD","IE00BZ08YS42.EUR","LU2089984988.USD","PJP","LU2242652126.USD","LU2468319806.SGD","BK4534","TBXU","IE0002141913.USD","IE00BFTCPJ56.SGD","BK1589","BK1521","LU0289739699.SGD","IE00BJJMRZ35.SGD","LU2112291526.USD","LU2242646821.SGD","PBE","BK4599","IBBQ","SG9999001440.SGD","BK4581","01177","BK1515","BK4533","BK4139","LU0122379950.USD","LU0320765992.SGD","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662215752","title":"Biogen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2662215752","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662215752?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:59","pubTimestamp":1787691540,"startTime":"0","endTime":"0","summary":"DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  advanced 1.21% to $220.77 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.32% to 7,677.28 and the Dow Jones Industrial Average  rising 0.30% to 53,577.40.This was the stock's third consecutive day of gains.Biogen Inc. closed 0.62% short of its 52-week high of $222.15, which the company reached on August 19th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  rose 0.53% to $273.14, Pfizer Inc.  rose 2.15% to $28.57, and AbbVie Inc.  rose 0.48% to $265.79.Trading volume  remained 712,698 below its 50-day average volume of 1.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 25, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIIB","PBE","IE00B19Z9Z06.USD","LU0889565916.HKD","LU0234570918.USD","IE00B894F039.SGD","BK4585","BK4533","BK4139","LU0109394709.USD","BMED","BK4588","BK4532","IE00B19Z9P08.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662370257","title":"Political and General News Events from August 25","url":"https://stock-news.laohu8.com/highlight/detail?id=2662370257","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662370257?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:25","pubTimestamp":1787664343,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 25Aug 25 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL4N44M0UU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU1061106388.HKD","LU2242646821.SGD","LU2112291526.USD","BK4588","BK4599","IE00BJJMRZ35.SGD","LU0122379950.USD","IE00B4R5TH58.HKD","BK4585","IBB","LU2242652126.USD","BK4581","PBE","LU0058720904.USD","LU1057294990.SGD","IE00BFTCPJ56.SGD","LU0889565916.HKD","LU1571399168.USD","LU1983299246.USD","LU2468319806.SGD","BBH","IBBQ","BK4566","BIB","LU0109394709.USD","BK4533","IE00BJT1NW94.SGD","IE00B2B36J28.USD","PJP","TBXU","LU0868494617.USD","AMGN","LU0289739699.SGD","LU1023059063.AUD","IE0002141913.USD","BK4534","IE0009355771.USD","LU0320765992.SGD","SG9999001440.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}